George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMalvern Intl Regulatory News (MLVN)

Share Price Information for Malvern Intl (MLVN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 20.00
Bid: 19.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 2.00 (10.526%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 20.00
MLVN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing and Total Voting Rights

10 Nov 2022 07:00

RNS Number : 8951F
Malvern International PLC
10 November 2022
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("UK MAR").

 

 

10 November 2022

 

Malvern International plc

("Malvern" or the "Company")

 

Placing

Total Voting Rights

 

Malvern International plc (AIM: MLVN), the global learning and skills development partner, announces that it has undertaken a placing of 2,500,000 new ordinary shares of 1p each ("New Ordinary Shares") at a price of 8 pence per share (the "Placing Price") to raise £200,000 (before expenses) which will be used principally to redeem the final tranche of Company's outstanding loan notes ("Loan Notes").

 

The Placing Price represents a discount of approximately 3.03 per cent to the closing mid-market price of 8.25 pence per Ordinary Share on 9 November 2022, being the latest practicable business day prior to the publication of this Announcement.

 

The outstanding Loan Notes amounting to £178,102 are held by Mr Ho Peng Cheong (the "Holder"). The Holder has agreed that the outstanding principal of the Loan Notes may be redeemed at a five per cent. discount. In addition, the Holder has agreed to sell all the ordinary shares he holds in the ordinary share capital of the Company (the "Sale"), amounting to 917,600 ordinary shares (the "Sale Shares") at the Placing Price in transactions which are expected to be executed today. Certain Directors of the Company have indicated their intention to purchase in aggregate 547,004 Sale Shares amounting to £43,760 as follows:

 

Name

Amount

Number of Shares

Richard Mace

£16,000

200,002

Daniel Fisher

£1,500

18,750

Mark Elliott

£13,130

164,126

Alan Carroll

£13,130

164,126

 

 

 Placing and Sale summary

 

· The Placing has raised £200,000 (before expenses) through the issue of 2,500,000 New Ordinary Shares at the Placing Price.

· The New Ordinary Shares represent approximately 10.2 per cent. of the Enlarged Issued Ordinary Share Capital.

· The Sale will generate proceeds to the Holder of £73,408 through the sale of 917,600 Sale Shares at the Placing Price.

· The Sale Shares represent approximately 4.2 per cent. of the Existing Issued Ordinary Share Capital and represent approximately 3.8 per cent of the Enlarged Issued Ordinary Share Capital

 

The net proceeds of the Placing will be used to satisfy the outstanding principal of the Loan Notes, outstanding interest on the Loan Notes at the date of redemption and to pay costs.

 

Reasons for the Loan Note redemption, Placing and Sale

 

The amount of principal outstanding on the Loan Notes is £178,102. Under existing arrangements that amount is redeemable on 31 December and if not settled by 31 January 2022 is convertible into Ordinary Shares.

 

The Company has agreed with the Holder that full and final settlement of the final tranche of the principal of outstanding Loan Notes can be made for £169,196.90 which represents a five per cent. discount. In addition, the Holder has agreed to the sale of the Sale Shares, being all of his shares in the ordinary share capital of the Company, at the Placing Price.

 

Previous tranches of Loan Notes have been converted and, when possible, sold by the Holder which the Directors consider has been a drag on the share price. The Directors believe a conversion of the final tranche of loan notes would exacerbate this issue. They are therefore pleased to have undertaken a successful placing to fund the redemption of the Loan Notes while also facilitating the Sale, which the Directors believe are in the best interests of shareholders. 

 

 

Placing information

 

WH Ireland Limited ("WH Ireland") acted as sole bookrunner in connection with the Placing.

 

The Placing has not been underwritten by WH Ireland and is conditional inter alia on the placing agreement dated 9 November 2022 between the Company and WH Ireland (the "Placing Agreement") not having been terminated and Admission.

 

The New Ordinary Shares will be issued, credited as fully paid, and will rank pari passu with the Ordinary Shares in issue in the capital of the Company, including the right to receive all dividends and other distributions (if any) declared, made or paid on or in respect of such shares after the date of their issue.

 

 

Admission to trading

 

Application will be made to the London Stock Exchange for Admission, which is expected to become effective and dealings in the New Ordinary Shares to commence at, 8.00 a.m. on or around 14 November 2022.

 

 

Total Voting Rights

 

Following Admission, the Company's issued ordinary share capital will consist of 24,442,400 Ordinary Shares of which none are held in treasury. Therefore the total voting rights in the Company is 24,442,400 and Shareholders may use this figure as the denominator by which they are required to notify their interest in, or change to their interest in, the Company under the Disclosure Guidance and Transparency Rules.

 

 

For further information please contact:

 

Malvern International Plc

www.malverninternational.com

Mark Elliott - Chairman

Via the website

Richard Mace - Chief Executive Officer

 

WH Ireland (NOMAD & Broker)

www.whirelandcb.com

Mike Coe / Sarah Mather

0207 220 1666

Notes to Editors:

Malvern International is a learning and language skills development partner, offering international students essential academic and English language skills, cultural experiences and the support they need to thrive in their academic studies, daily life and career development.

University Pathways  - on and off-campus university pathway programmes helping students progress to a range of universities, as well as in-sessional and pre-sessional courses.

 Malvern House Schools  - British Council accredited English Language Training at English UK registered schools in London, Brighton and Manchester.

Malvern Online Academy  - British Council accredited online school, offering supported tuition to students from around the world in English language, higher education, and professional education.

Juniors and summer camps  - fully-immersive summer residential English language camps and bespoke group programmes for 13 to 18 year olds.

For further investor information go to  www.malverninternational.com

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEBLBRTMTJMBIT
Date   Source Headline
23rd Apr 20247:00 amRNSAnnual Report & Notice of AGM
10th Apr 20247:00 amRNSFinal Results
4th Mar 202412:00 pmRNSIssue of Warrants
14th Feb 202411:02 amRNSCorrection: Trading Update
15th Jan 20245:22 pmRNSHolding(s) in Company
15th Nov 20237:00 amRNSContract extension
15th Nov 20237:00 amRNSAppointment of CDO & Grant of EMI Options
3rd Oct 20237:00 amRNSClosure of Malvern House, Brighton
29th Sep 20237:00 amRNSInterim Results
24th Aug 20237:00 amRNSTrading Update
30th May 202312:37 pmRNSResult of AGM
30th May 20237:00 amRNSTrading Update
15th May 20237:00 amRNSPartnership Agreement
26th Apr 20237:00 amRNSAnnual Report & Notice of Annual General Meeting
12th Apr 20234:23 pmRNSDirector Dealing
12th Apr 20237:00 amRNSDirector Dealing
6th Apr 20237:00 amRNSFinal Results
3rd Apr 202310:00 amRNSHolding(s) in Company
9th Feb 20237:00 amRNSTrading Update
20th Jan 20234:40 pmRNSSecond Price Monitoring Extn
20th Jan 20234:35 pmRNSPrice Monitoring Extension
20th Jan 20232:05 pmRNSSecond Price Monitoring Extn
20th Jan 20232:00 pmRNSPrice Monitoring Extension
19th Jan 20234:40 pmRNSSecond Price Monitoring Extn
19th Jan 20234:35 pmRNSPrice Monitoring Extension
30th Nov 20224:11 pmRNSGrant of Options
10th Nov 20221:48 pmRNSDirectors Dealing
10th Nov 202210:36 amRNSHolding(s) in Company
10th Nov 202210:31 amRNSDirectors Dealing
10th Nov 20227:00 amRNSPlacing and Total Voting Rights
2nd Nov 20223:31 pmRNSCorrection: Result of General Meeting and TVR
2nd Nov 202211:44 amRNSResult of General Meeting and Total Voting Rights
2nd Nov 20227:00 amRNSTrading Update
17th Oct 20227:00 amRNSShare Reorganisation an Notice of General Meeting
17th Oct 20227:00 amRNSShare Reorganisation and Notice of General Meeting
4th Oct 20224:24 pmRNSHolding(s) in Company
29th Sep 20228:23 amRNSHolding(s) in Company
27th Sep 20228:25 amRNSDirector dealings
22nd Sep 20228:42 amRNSDirector dealings
21st Sep 20224:41 pmRNSSecond Price Monitoring Extn
21st Sep 20224:36 pmRNSPrice Monitoring Extension
15th Sep 20227:00 amRNSHalf-year Report
25th Aug 20227:00 amRNSTrading update
9th Aug 20225:11 pmRNSHolding(s) in Company
1st Aug 20227:00 amRNSLoan Conversion and Issue of Equity
8th Jun 202211:33 amRNSResult of AGM & Director Disclosure
23rd May 20227:00 amRNSContract award
4th May 20227:00 amRNSFinal Results
4th Mar 20227:00 amRNSDebt restructuring
4th Mar 20227:00 amRNSTrading update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.